Iorgulescu, J. Bryan
Reardon, David A.
Chiocca, E. Antonio
Wu, Catherine J.
Article History
First Online: 6 August 2018
Competing interests
: D.A.R. reports receiving honoraria, advisory, and consultant fees from Abbvie; Agenus; Bristol-Myers Squibb; Celldex; EMD Serono; Genentech/Roche; Inovio; Merck; Merck KGaA; Monteris; Novocure; Oncorus; Oxigene; Regeneron; Stemline; and Taiho Oncology, Inc. E.A.C. reports receiving consultant and advisory fees from Advantagene and Dnatrix. C.J.W. is cofounder of Neon Therapeutics and a member of its scientific advisory board. All other authors declare that they have no competing interests.